Effect of centrally administered opioid receptor agonists on CSF and plasma oxytocin concentrations in dogs

American Journal of Veterinary Research
D C BrownJ A Amico

Abstract

To measure oxytocin concentrations in blood and CSF following central administration of opioid agonists in dogs. 5 male dogs. In a crossover design, CSF and blood were collected immediately before and 15 and 30 minutes after cisternal administration of D-Ala2, MePhe4, Gly-ol-enkephalin (DAMGO, a mu-receptor agonist); D-Pen, pCl-Phe4, D-Pen5-enkephalin (a delta-receptor agonist); U50488H (a kappa-receptor agonist); morphine; and saline (0.9% NaCl) solution. Plasma oxytocin concentration was significantly increased 15 minutes after administration of DAMGO and 30 minutes after administration of U50488H, compared with concentrations obtained after administration of saline solution. Concentration of oxytocin in CSF was significantly decreased 30 minutes after administration of U50488H, compared with concentration after administration of saline solution. Results suggest that in male dogs, activation of centrally located mu and kappa receptors elicits an overall excitatory effect on neurons that regulate peripheral release of oxytocin, whereas activation of centrally located kappa receptors elicits an overall inhibitory effect on neurons that regulate central release. These results are in contrast to those reported for other species, ...Continue Reading

References

Dec 17, 1991·European Journal of Pharmacology·B J Van de HeijningT B Van Wimersma Greidanus
Oct 8, 1990·Brain Research·P RousselotD T Theodosis
Oct 1, 1987·The Journal of Physiology·V L Go, T L Yaksh
Jan 1, 1985·The Journal of Clinical Endocrinology and Metabolism·J A AmicoA G Robinson
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·Q J PittmanF E Bloom
May 1, 1984·Anesthesiology·G NordbergB Dahlström
May 1, 1981·The Journal of Clinical Endocrinology and Metabolism·J A AmicoA G Robinson
Jun 1, 1994·Journal of Veterinary Pharmacology and Therapeutics·E P SteffeyM Tagawa
Apr 29, 1993·Regulatory Peptides·T B van Wimersma Greidanus, B J van de Heijning
Jul 22, 1993·Annals of the New York Academy of Sciences·I C Robinson, J E Coombes
Mar 1, 1993·The Veterinary Clinics of North America. Small Animal Practice·R E Roberts, B A Selcer

❮ Previous
Next ❯

Citations

Jan 22, 2003·Peptides·Richard J Bodnar, Maria M Hadjimarkou
Aug 6, 2013·Journal of Physiology and Biochemistry·Ahmet AyarHaluk Kelestimur
Jun 8, 2015·Biological Psychiatry·Gareth Leng, Mike Ludwig
May 21, 2016·Medicinal Research Reviews·Leonid N MaslovJames M Downey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.